Alnylam Pharmaceuticals
ALNY
#550
Rank
ยฃ32.22 B
Marketcap
ยฃ243.90
Share price
-5.89%
Change (1 day)
10.37%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) Fails to deliver data

Key failure to deliver metrics for Alnylam Pharmaceuticals :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Alnylam Pharmaceuticals (ALNY) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Alnylam Pharmaceuticals (ALNY) - since 2013

Volume in USD (price x number of shares), data since 2013

Alnylam Pharmaceuticals (ALNY) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026ยฃ0 M-99.99%
2025ยฃ42.8 M-0.86%
2024ยฃ43.18 M-16.96%
2023ยฃ51.99 M-66.55%
2022ยฃ0.15 B200.46%
2021ยฃ51.74 M-9.83%
2020ยฃ57.38 M52.34%
2019ยฃ37.66 M46.52%
2018ยฃ25.7 M-70.97%
2017ยฃ88.54 M191.96%
2016ยฃ30.32 M-14.94%
2015ยฃ35.65 M68.07%
2014ยฃ21.21 M152.1%
2013ยฃ8.41 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novartis
NVS
ยฃ93.01 Mยฃ0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ10.89 Mยฃ69.64 M๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
ยฃ4.5 Mยฃ68.25 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ3.82 Mยฃ21.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
N/Aยฃ5.34 M๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.11 Mยฃ7.23 M๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ53.08 Mยฃ87.14 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
ยฃ3.87 Mยฃ10.57 M๐Ÿ‡บ๐Ÿ‡ธ USA